Immunotech S.A

Address: Radiova 1, Prague, CZ-10A 10227, Czech Republic | Map/Directions >>

Profile: Immunotech S.A specializes in immunology. We provide isotopic and non-isotopic products. We manufacture and sell immunodiagnostic kits in RIA, ELISA and ILMA versions, sharing the same know-how of unique, patented technology of the solid phase coating with monoclonal & polyclonal antibodies. We offer immunoanalytical kits for diagnostic and research purposes.

FDA Registration Number: 3003385757
US Agent: David Davis / Beckman Coulter
Phone: +1-(469)-236-8180 E-Mail:

9 Products/Services (Click for related suppliers)

• Aldosterone Radioimmunoassay Test (FDA Code: CJM / 862.1045)

An aldosterone test system is a device intended to measure the hormone aldosterone in serum and urine. Aldosterone measurements are used in the diagnosis and treatment of primary aldosteronism (a disorder caused by the excessive secretion of aldosterone by the adrenal gland), hypertension caused by primary aldosteronism, selective hypoaldosteronism, edematous states, and other conditions of electrolyte imbalance.

• Androstenedione Radioimmunoassay Test (FDA Code: CIZ / 862.1075)

An androstenedione test system is a device intended to measure androstenedione (a substance secreted by the testes, ovary, and adrenal glands) in serum. Adrostenedione measurements are used in the diagnosis and treatment of females with excessive levels of androgen (male sex hormone) production.

• Angiotensin I and Renin Radioimmunoassay Test (FDA Code: CIB / 862.1085)

An angiotensin I and renin test system is a device intended to measure the level of angiotensin I generated by renin in plasma. Angiotensin I measurements are used in the diagnosis and treatment of certain types of hypertension.

• Estradiol Radioimmunoassay Test (FDA Code: CHP / 862.1260)

An estradiol test system is a device intended to measure estradiol, an estrogenic steroid, in plasma. Estradiol measurements are used in the diagnosis and treatment of various hormonal sexual disorders and in assessing placental function in complicated pregnancy.

• Estrone Radioimmunoassay Test (FDA Code: CGF / 862.1280)

An estrone test system is a device intended to measure estrone, an estrogenic steroid, in plasma. Estrone measurements are used in the diagnosis and treatment of numerous disorders, including infertility, amenorrhea, differentiation of primary and secondary ovarian malfunction, estrogen secreting testicular and ovarian tumors, and precocious puberty in females.

• Human Growth Hormone Radioimmunoassay (FDA Code: CFL / 862.1370)

A human growth hormone test system is a device intended to measure the levels of human growth hormone in plasma. Human growth hormone measurements are used in the diagnosis and treatment of disorders involving the anterior lobe of the pituitary gland.

• Ion Exchange Column with Colorimetry Delta-Aminolevulinic Acid (FDA Code: JKL / 862.1060)

Adelta -aminolevulinic acid test system is a device intended to measure the level ofdelta -aminolevulinic acid (a precursor of porphyrin) in urine.Delta -aminolevulinic acid measurements are used in the diagnosis and treatment of lead poisoning and certain porphyrias (diseases affecting the liver, gastrointestinal, and nervous systems that are accompanied by increased urinary excretion of various heme compounds includingdelta -aminolevulinic acid).

• Radioimmunoassay for Dehydroepiandrosterone Sulfate (FDA Code: JKC / 862.1245)

A dehydroepiandrosterone (free and sulfate) test system is a device intended to measure dehydroepiandrosterone (DHEA) and its sulfate in urine, serum, plasma, and amniotic fluid. Dehydroepiandrosterone measurements are used in the diagnosis and treatment of DHEA-secreting adrenal carcinomas.

• Testosterones and Dihydrotestosterone Radioimmunoassay (FDA Code: CDZ / 862.1680)

A testosterone test system is a device intended to measure testosterone (a male sex hormone) in serum, plasma, and urine. Measurement of testosterone are used in the diagnosis and treatment of disorders involving the male sex hormones (androgens), including primary and secondary hypogonadism, delayed or precocious puberty, impotence in males and, in females hirsutism (excessive hair) and virilization (masculinization) due to tumors, polycystic ovaries, and adrenogenital syndromes.